Related Experiment Video
Updated: Jul 20, 2025
09:32
Differentiation of Mouse Breast Epithelial HC11 and EpH4 Cells
Published on: February 27, 2020
8.9K
miR-203 drives breast cancer cell differentiation
Nuria G Martínez-Illescas1,2,3, Silvia Leal4, Patricia González5
1Department of Biochemistry and Molecular Biology, School of Biology, Complutense University, Madrid, Spain.
Breast Cancer Research : BCR
|August 4, 2023
Summary
MicroRNA 203 (miR-203) drives differentiation in breast cancer cells, reducing their self-renewal and invasive potential. This finding offers a promising new strategy for differentiation therapy against aggressive tumors.
Area of Science:
- Oncology
- Molecular Biology
- Stem Cell Biology
Background:
- Malignant tumors often contain dedifferentiated cells with enhanced survival and relapse capabilities.
- Current differentiation therapies face challenges due to tumor heterogeneity and limited clinical translation.
Purpose of the Study:
- To investigate the role of microRNA 203 (miR-203) in promoting cancer cell differentiation.
- To evaluate miR-203 as a potential therapeutic agent for breast cancer.
Main Methods:
- Utilized mouse in vivo models and 3D organoid cultures (mouse and human-derived).
- Assessed the impact of miR-203 on cancer cell self-renewal, plasticity, and differentiation potential.
Main Results:
- miR-203 was found to promote the differentiation of mammary gland tumor cells.
- miR-203 influenced breast cancer cell self-renewal, plasticity, and differentiation.
- miR-203 inhibited tumor cell growth in vivo.
Conclusions:
- miR-203 is a potent inducer of differentiation in breast cancer cells.
- miR-203 holds promise as a therapeutic tool to target tumor-maintaining and regenerative capabilities.
- This research advances differentiation-based antitumor strategies.
